ECGI Announces Definitive Agreement to Acquire East West Pharma Group

Rhea-AI Summary

ECGI Holdings Inc. (OTC: ECGI), operating as Elite Cannabis Group, announced a Definitive Agreement to acquire East West Pharma Group, Inc. (EWPG), a Wyoming corporation specializing in cannabis extraction. This acquisition positions ECGI to access the $2.7 billion cannabis manufacturing market. ECGI will gain state-of-the-art extraction equipment capable of processing up to 500 pounds of industrial hemp per hour, potentially generating $208,500 of material processed each hour. Additionally, key personnel, including extraction experts from Yunnan University, will be integrated into ECGI's operations, enhancing its competitive edge in the cannabis sector.

Positive

• Acquisition of East West Pharma Group strengthens ECGI's position in the $2.7 billion cannabis market.
• State-of-the-art extraction equipment allows processing of large volumes, increasing production efficiency.
• Integration of experienced personnel from EWPG enhances technical capabilities and expertise.

Negative

• None.

LOS ANGELES, Feb. 16, 2023 /PRNewswire/ -- ECGI HOLDINGS INC. (OTC: ECGI) (ECGI or the Company), D/B/A Elite Cannabis Group Incorporated, a Nevada-based portfolio company pivoting into the legal cannabis and cannabinoid marketplace, is excited to announce the signing of a Definitive Agreement (the "Agreement") to acquire East West Pharma Group, Inc. ("EWPG"), a Wyoming corporation with specialized equipment and experienced personnel, including leaders in the cannabinoid extraction and product manufacturing space.

As discussed in the ECGI's release dated February 8, this acquisition represents a shift in the Company's strategy by becoming part of the $2.7 Billion Cannabis Manufacturing, Extract, and Concentrates marketplace.

Through the Agreement, the Company is acquiring specialized equipment. According to East West Pharma Group, the extraction equipment was custom built to process very large volumes of industrial hemp (up to 500 pounds per hour) and distill crude material through a high-volume liquid to liquid (L2L) process designed to generate optimal refined product.

Assuming, outdoor prices quoted by CannabisBenchMarks.com's Feb 3, 2023, outdoor spot price at $417 per pound, the equipment can process up to $208,500 of material per hour.

The acquisition also includes key personnel, including Dr. Zhihong Zhou, Ph.D., the dean of extraction of Yunnan University, School of Traditional Chinese Medicine (TCM). Yunnan University is considered the foremost research facility of TCM in China, and perhaps the top TCM facility in the world.

Stanley Zhang, an expert in cannabis extraction and processing, and Sam Lai, an engineer with a focus on liquid-to-liquid extraction of cannabis cannabinoids and manufacturing of finished goods, will also be joining ECGI as part of the acquisition deal.

"Now that the Agreement is in place, we are excited to hit the ground running," noted ECGI CEO, Danny Wong. "This acquisition represents plug-and-play access to one of the most dynamic cannabis product markets on the planet. We now have the relationships, equipment, and team to compete for significant market share."

About ECGI

ECGI Holdings, which plans to operate as Elite Cannabis Group, is reorganizing as an acquisition-oriented corporation with California-based targets including undercapitalized and distressed licensed cannabis assets, properties zoned for cannabis cultivation and processing, and cannabis companies operating in market sectors with nationwide expansion possibilities.

For additional information, please contact us at info@ecgiholdings.com.

Forward Looking Statements

This release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" and other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.

Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to, economic conditions, changes in the laws or regulations, demand for products and services of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.

View original content:https://www.prnewswire.com/news-releases/ecgi-announces-definitive-agreement-to-acquire-east-west-pharma-group-301748461.html

SOURCE ECGI Holdings

FAQ

What is the significance of ECGI's acquisition of East West Pharma Group?

The acquisition allows ECGI to enter the lucrative $2.7 billion cannabis manufacturing market, enhancing its operational capabilities.

How will the extraction equipment benefit ECGI?

The specialized extraction equipment can process up to 500 pounds of industrial hemp per hour, potentially generating significant revenue.

Who are the key personnel joining ECGI from East West Pharma Group?

Notable personnel include Dr. Zhihong Zhou from Yunnan University and experts in cannabis extraction, enhancing ECGI's expertise.

What are ECGI's future plans following the acquisition?

ECGI aims to operate as an acquisition-oriented company targeting undercapitalized cannabis assets for expansion.